Disseminated intravascular coagulation DIC is categorized into bleeding, organ failure, massive bleeding, and non-symptomatic types according to the sum of vectors for hypercoagulation and hyperfibrinolysis. The British Committee for Standards in Haematology, Japanese Society of Thrombosis and Hemostasis, and the Italian Society for Thrombosis and Haemostasis published separate guidelines for DIC; however, there are several differences between these three sets of guidelines. The first and second criteria can be used to diagnose the bleeding or massive bleeding types of DIC, while the third criteria cover organ failure and the massive bleeding type of DIC. Treatment of underlying conditions is recommended in three types of DIC, with the exception of massive bleeding.

Author:Malahn Kazraran
Language:English (Spanish)
Published (Last):24 March 2009
PDF File Size:4.73 Mb
ePub File Size:3.6 Mb
Price:Free* [*Free Regsitration Required]

This may be done with heparin, an anticoagulant, often called a blood thinner. Adalahhsurgerymajor traumacancercomplications of pregnancysnake bitesfrostbiteburns [1]. A reduced fibrinogen level is a valuable indicator regarding a diagnosis of DIC due to leukemia or obstetric diseases; however, it is not observed in most septic DIC patients [ 3 ].

PC may be administered at higher levels in patients perceived to be at high risk of bleeding based on other clinical or laboratory features [ 44 ]. Apr 22, Xherald -- The most appropriate, exclusive, realistic and admirable market research report is delivered with devotion depending upon your business needs. With the precise base year and the historic year, estimations and calculations are performed in this Global Disseminated Intravascular Coagulation DIC Market report.

Market share analysis and key trend analysis are the key accomplishing factors in this Global Disseminated Intravascular Coagulation DIC Market report.

Report helps you recognize how the market is going to perform in the forecast years by giving you information about market definition, classifications, applications, and engagements. Market Analysis and Insights: Disseminated Intravascular Coagulation DIC market is expected to gain market growth in the forecast period of to Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

The report puts light on the types of customers, product-buyer insights, market changes over last few years, reactions of various geographic regions, new developments in the market, actions of other corporate players and more. All the statistics are signified in graphical and tabular format for a clear understanding on facts and figures.

By accomplishing a motivation from the marketing strategies of rivals, businesses can set up inventive ideas and striking sales targets which in turn make them achieve competitive advantage over its competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve.

In addition, high diagnostic rate and improvement in healthcare facilities are some of the impacting factors that drives the market growth. Nevertheless, limited revenue opportunities coupled with high treatment cost significantly hinder the growth of this market. Disseminated Intravascular Coagulation DIC is a type of thrombotic microangiopathy haematological disorders that results in the abnormal production of thrombin and fibrin throughout the small blood vessels which eventually results in the necrosis of tissues and excessive bleeding.

This Disseminated Intravascular Coagulation DIC market report provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market.

To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal. Based on treatment, the market is segmented into medicines, transfusions, surgery and others. The medication section is further categorized into antibiotics, heparin and antithrombin which may be used to help with coagulation problems.

The route of administration segment for global Disseminated Intravascular Coagulation DIC market is segmented into oral and injections On the basis of end-users, the market is segmented into hospitals, homecare, speciality centres and others On the basis of distribution channel, the market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy Global Disseminated Intravascular Coagulation DIC Market Country Level Analysis Disseminated Intravascular Coagulation DIC market is analysed and market size information is provided by country, treatment, route of administration end-users and distribution channel as referenced above.

Geographically, North America especially the United States is highly attractive market for global Disseminated Intravascular Coagulation DIC market due to the high demand of diseases specific treatment, rise in adoption of newer technologies, presence of refined healthcare expenditure and increased patient awareness level as well as high prevalence of bleeding disorders.

Europe is considered a second largest growing regional segment owing to the presence of global marketed players in this region and growing cases of Disseminated Intravascular Coagulation DIC. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. About Data Bridge Market Research: An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Gejala-gejala DIC umumnya sangat terkait dengan penyakit yang mendasarinya, ditambah gejala tambahan akibat trombosis, emboli, disfungsi organ, dan perdarahan. Keadaan ini menyebabkan perdarahan secara menyeluruh dengan koagulopati konsumtif yang parah. Banyak penyakit dengan beraneka penyebab dapat menyebabkan DIC, namun bisa dipastikan penyakit yang berakhir dengan DIC akan memiliki prognosis malam. Meski DIC merupakan keadaan yang harus dihindari, pengenalan tanda dan gejala berikut penatalaksanaannya menjadi hal mutlak yang tak hanya harus dikuasai oleh hematolog, namun hampir semua dokter dari berbagai disiplin.

Terjadinya DIC dipicu oleh trauma atau jaringan nekrotik yang akan melepaskan faktor-faktor pembekuan darah. Endotoksin dari bakteri gram negatif akan mengaktivasi beberapa langkah pembekuan darah.

Pathophysiology[ edit ] The coagulation cascade of secondary haemostasis. Under homeostatic conditions, the body is maintained in a finely tuned balance of coagulation and fibrinolysis. The activation of the coagulation cascade yields thrombin that converts fibrinogen to fibrin ; the stable fibrin clot being the final product of hemostasis.

The fibrinolytic system then functions to break down fibrinogen and fibrin. Activation of the fibrinolytic system generates plasmin in the presence of thrombin , which is responsible for the lysis of fibrin clots. Necessary cookies are absolutely essential for the website to function properly.

This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information. Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies.

It is mandatory to procure user consent prior to running these cookies on your website. This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Close Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.

We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always Enabled. Non-necessary Non-necessary.


Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Disseminated intravascular coagulation DIC involves abnormal, excessive generation of thrombin and fibrin in the circulating blood. During the process, increased platelet aggregation and coagulation factor consumption occur. DIC that evolves slowly over weeks or months causes primarily venous thrombotic and embolic manifestations; DIC that evolves rapidly over hours or days causes primarily bleeding. Severe, rapidly evolving DIC is diagnosed by demonstrating thrombocytopenia, an elevated partial thromboplastin time and prothrombin time, increased levels of plasma D-dimers or serum fibrin degradation products , and a decreasing plasma fibrinogen level. Treatment includes correction of the cause and replacement of platelets, coagulation factors in fresh frozen plasma , and fibrinogen in cryoprecipitate to control severe bleeding. Heparin is used as therapy or prophylaxis in patients with slowly evolving DIC who have or are at risk of venous thromboembolism.


Disseminated Intravascular Coagulation (DIC)

Disseminated intravascular coagulation DIC is a condition in which blood clots form throughout the body, blocking small blood vessels. Relatively common causes include sepsis , surgery , major trauma , cancer , and complications of pregnancy. Treatment is mainly directed towards the underlying condition. The onset of DIC can be sudden, as in endotoxic shock or amniotic fluid embolism , or it may be insidious and chronic, as in cancer. DIC can lead to multiorgan failure and widespread bleeding. DIC can occur in the following conditions: [5] [6] [7] [8].

Related Articles